Cargando…
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study
BACKGROUND: Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN). However, whether telmisartan, an ARB with peroxisome proliferator-activated receptor γ (PPAR-γ)–modulating effects, has additional benefits compared to other...
Autores principales: | Liu, Chi-Hung, Sung, Pi-Shan, Li, Yan-Rong, Huang, Wen-Kuan, Lee, Tay-Wey, Huang, Chin-Chang, Lee, Tsong-Hai, Chen, Tien-Hsing, Wei, Yi-Chia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289120/ https://www.ncbi.nlm.nih.gov/pubmed/34280191 http://dx.doi.org/10.1371/journal.pmed.1003707 |
Ejemplares similares
-
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
por: Liu, Chi-Hung, et al.
Publicado: (2020) -
Colchicine Use and Risks of Stroke Recurrence in Acute Non-Cardiogenic Ischemic Stroke Patients: A Population-Based Cohort Study
por: Liu, Chi-Hung, et al.
Publicado: (2021) -
Antiproliferative and apoptotic effects of telmisartan in human glioma cells
por: Chang, Yung-Lung, et al.
Publicado: (2023) -
Efficacy and Safety of Azilsartan and Telmisartan in Hypertensive Patients
por: Kumar, Alok, et al.
Publicado: (2021) -
Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype
por: Hu, Wenjing, et al.
Publicado: (2020)